chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I did end up vomitting; after 48 hours, she woke up with a 150 heart rate,; very nauseous; Irregular heart rate; She started with pain at injection site that is still there; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (after 48 hours, she woke up with a 150 heart rate,), HEART RATE IRREGULAR (Irregular heart rate), NAUSEA (very nauseous), INJECTION SITE PAIN (She started with pain at injection site that is still there) and VOMITING (I did end up vomitting) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Colonoscopy (10 years ago) in 2011. Concomitant products included IBUPROFEN for Allergy, MORPHINE from 10-Jan-2015 to an unknown date for Chronic back pain, DIAZEPAM (VALIUM) from 10-Jan-2015 to an unknown date for Muscle spasms.    On 20-Mar-2021 at 3:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced INJECTION SITE PAIN (She started with pain at injection site that is still there). On 20-Mar-2021 at 3:15 PM, the patient experienced HEART RATE IRREGULAR (Irregular heart rate). On 23-Mar-2021 at 3:30 AM, the patient experienced TACHYCARDIA (after 48 hours, she woke up with a 150 heart rate,). 23-Mar-2021 at 3:30 AM, the patient experienced NAUSEA (very nauseous). On 23-Mar-2021 at 5:00 AM, the patient experienced VOMITING (I did end up vomitting). On 20-Mar-2021, HEART RATE IRREGULAR (Irregular heart rate) had resolved. On 23-Mar-2021, TACHYCARDIA (after 48 hours, she woke up with a 150 heart rate,), NAUSEA (very nauseous) and VOMITING (I did end up vomitting) had resolved. At the time of the report, INJECTION SITE PAIN (She started with pain at injection site that is still there) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Heart rate: 160 (High) Her heart rated stayed in high 80s for about 2 days..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was reported to have cervical stenosis from 10-JUL-2021. Patient reported that 3 weeks after vaccination she had a test for stenosis and was pricked in the same muscle that the vaccine was injected into. Patient reported that she did vomit every time on consumption of PEG. The patient was reported to have undergone colonoscopy 10 years ago. The patient reported that she had to take 5 mg of valium and 30 mg of morphine to maintain her heart rate within the normal range,   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up was received on 26-MAY-2021. Reporter's address was updated. Patient demographics- height, weight, race and ethnicity were added. Patient's past medical history was updated. Vaccination time was added. Concomitant medications were updated. Events-nausea, vomiting and tachycardia onset time was added and all events' outcome was updated to recovered/resolved. Primary Source Reporter's causality was updated.
Large amount of bruising, swelling, pain distal to injection site accompanied by numbness and tingling to left ring and small finger. Diagnosed as Hematoma secondary to MMR injection. Experiencing ulnar nerve irritation d/t swelling. Negative for compartment syndrome, abscess or cellulitis.
it's actually in pain/ it's hurting; still having heart trouble; heart is beating fast; Legs are shaking, legs started really really shaking; Clonus; Really nervous; This spontaneous case was reported by a consumer and describes the occurrence of ANGINA PECTORIS (it's actually in pain/ it's hurting) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Spinal cord injury (T12 vertebrae fracture), Vertebral fracture, Heart rate increased (had a little episode of a little bit of a fast heart rate and they gave him heart monitors, but he did not have any heart condition, it was just one episode.) in 1998 and Surgery (Fused from T10 to L2.). Concurrent medical conditions included Disability.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021, the patient experienced TREMOR (Legs are shaking, legs started really really shaking), CLONUS (Clonus) and NERVOUSNESS (Really nervous). 21-Aug-2021, the patient experienced HEART RATE INCREASED (heart is beating fast). On 01-Sep-2021, the patient experienced ANGINA PECTORIS (it's actually in pain/ it's hurting) (seriousness criterion medically significant) and CARDIAC DISORDER (still having heart trouble). At the time of the report, ANGINA PECTORIS (it's actually in pain/ it's hurting), TREMOR (Legs are shaking, legs started really really shaking), CLONUS (Clonus), NERVOUSNESS (Really nervous) and HEART RATE INCREASED (heart is beating fast) had not resolved and CARDIAC DISORDER (still having heart trouble) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Aug-2021, Heart rate: high (High) Heart rate elevated - high. On 01-Sep-2021, Heart rate: high (High) still high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received contains significant information. Events Angina pectoris, Cardiac disorder and Heart rate increased are added; Case is upgraded to serious.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Approximately 10-15 minutes after injections, vomiting, diarrhea: flushed red cheeks with white T99, HR120 BP64/50
diarrhea; vomiting; extreme tiredness; My arm is sometimes paining me a little and jolts; rash/rash is still raised and quite red and ugly; bruise is beginning to fade; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 12Apr2021 for covid-19 immunisation. Medical history and concomitant medication were not reported. The patient reported, she had a weird prickly rash on her arm where they gave the Pfizer COVID vaccine injection on 12Apr2021. She stated the bruise is beginning to fade, but she still has the rash. Her arm is sometimes paining me a little and jolts me a little. The rash is still raised and quite red and ugly. It's all bumpy and raised. She stated she had diarrhea, vomiting, and extreme tiredness. She is asking if this is normal and if she should receive the second dose? She didn't get vomiting or rash. Outcome of event for bruise is beginning to fade was recovering and for rest of the events it was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Almost immediate reaction of significant discomfort at injection site, continued for several days, gradually escalating to the point where she feels it is quite severe. She has some discomfort radiating down to forearm and up to shoulder from injection site. Vioxx 25/BID x 4 days.
Information had been received on 19-APR-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient (age unknown) was inoculated with ZOSTAVAX on or about 30-SEP-2013 at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles (dosage and lot#/expiration not reported). The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster (onset not reported). On or about 12-AUG-2014, patient was treated by a physician for an ongoing painful rash which was diagnosed as shingles. Although shingles is an incurable viral condition, patient was prescribed acyclovir for management of her symptoms. As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages.  Additional information has been requested.
her mom got UTI and her doctor prescribed antibiotic wanted to ask if it will affect the vaccine; This is a spontaneous report from a contactable consumer via a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (2 weeks ago) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 14Feb2021 (2 days ago), the patient got uti and her doctor prescribed antibiotic wanted to ask if it will affect the vaccine. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
On day one after vaccine continuing for two days severe arm pain radiating from neck to fingertips with twitching in fingertips.   Day 3 severe migraine for 14 hours, fever of 102, chills and body aches, sinus pain, minor cough, major fatigue.   Day 4 migraine, sinus pain, fatigue   Day 14 injection site swelling, itching, welt.   Frequently since vaccine minor headaches, sinus pain.
Patient stated that experienced significant pain near the injection site (about 5 inches below the shoulder the very morning after receiving the vaccine. She described it as a dull ache and the pain was very constant (pain intensified when using that arm directly, could hardly lift anything or use it). The patient reported to the pharmacy 2 days after the vaccination (48 hours had elapsed) to report this. The area was still visibly very red and hot to the touch, a mostly circular pattern roughly 4 inches in diameter with the addition of a line extending outward.  Patient had not taken any medication, Benadryl was recommended to her to start, if no improvement she should visit an urgent care for follow-up.
Client was vaccinated with Pfizer Covid vaccines on 4/23 and 5/13/2021.  Client symptomatic for Covid on 7/19 and tested PCR + on 7/20/2021.  Mild symptoms.  Definite contact with Covid + person 5 days prior to symptom onset.  Reported because this is a case of  Covid illness after complete vaccination series.
Pt c/o HA & dizziness 30 min after getting vaccine. Denied CP, SOB, N/V. DIB; speaks in full sentences. Mentating well. VS stable. BP 103-104/53-58; HR 62-68; RR 18-19; 98-100% on RA. Encourage to drink water. Pt verbalized feeling better. Released from vaccination site in stable condition & denied any dizziness, ambulated well & steady
Shingles; Ministroke; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and TRANSIENT ISCHAEMIC ATTACK (Ministroke) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) for B-cell chronic lymphocytic leukaemia.    No known allergies.  Concurrent medical conditions included Gout and Diabetic. Concomitant products included ALLOPURINOL, PARACETAMOL (TYLENOL), METFORMIN HCL, LOSARTAN POTASSIUM and NAPROXEN for an unknown indication.   On 20-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and IBRUTINIB (IMBRUVICA) (Oral) 420 milligram once a day. On 21-Apr-2022, the patient experienced HERPES ZOSTER (Shingles) (seriousness criterion hospitalization) and TRANSIENT ISCHAEMIC ATTACK (Ministroke) (seriousness criteria hospitalization and medically significant). The patient was hospitalized on 21-Apr-2022 due to HERPES ZOSTER and TRANSIENT ISCHAEMIC ATTACK. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown and TRANSIENT ISCHAEMIC ATTACK (Ministroke) was resolving.            Company comment: This is a spontaneous case concerning a 64-year-old male patient with medical history of B-cell chronic lymphocytic leukaemia and diabetes, who experienced the serious unexpected events transient ischaemic attack and herpes zoster, that lead to hospitalization. Events occurred approximately 5 months after the third dose of mRNA-1273.  Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) for B-cell chronic lymphocytic leukaemia. Patient´s reported  medical history remains a confounder for events. The benefit-risk relationship of mRNA-1273 is not affected by this report.  The patient had other concomitant therapy of multi for him.   The reporter's causality with IMBRUVICA(IBRUTINIB) for the events of Herpes zoster and transient ischaemic attack was not provided.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.; Sender's Comments: Company comment: This is a spontaneous case concerning a 64-year-old male patient with medical history of B-cell chronic lymphocytic leukaemia and diabetes, who experienced the serious unexpected events transient ischaemic attack and herpes zoster, that lead to hospitalization. Events occurred approximately 5 months after the third dose of mRNA-1273.  Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) for B-cell chronic lymphocytic leukaemia. Patient´s reported  medical history remains a confounder for events. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Day of vaccination arm was slightly tender. Day 6 my sleep was disturbed about 2 AM by a sick feeling (slight nausea and headache).  Got out of bed at 5 AM with headache still present. Fever of 99.4 about 7AM.  Headache continued on and off all day with 2 Tylenol.  Fever went down but rose to 99.4 approx. 8PM no headache.  Woke today, Thursday, at 5 with no headache but a fever of 100.4; went back to bed until 6. After a shower, my temp was down to 99. After exercise, it was 98.  Feeling okay right now.
pt returned  following day quarter-sized raised bumps on back; seen by MD stated that pt had an adverse reaction to flu vax;
I developed a headache almost immediately. Thirty minutes after receiving dose 1 of the Moderna Covid 19 vaccine my face, ears, neck, and chest turned bright red. My neck, face and ears swelled up. The skin was hot to touch and painful; it felt like pins and needles. I took one 200 mg Ibuprofen and held cool compresses to my skin. The swelling and redness subsided within 20-30 minutes. Four hours later, I was fatigued. The next day (Saturday, October 2, 2021), I was dizzy, had full body aches, joint pain, a headache, nausea, a fast heart beat (higher than normal for my resting heart rate; it was in the 120s). My arm hurt terribly at the site of injection it swelled up with a big lump, its very tender, and the skin turned red around the injection and itches. After 48 hours, the general side effects subsided. The injection site reactions have shown little to no improvement.
Pediatric dose probably  given to adult; Pediatric dose probably  given to adult; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 45-year-old female patient who received HBV (Engerix B) (batch number M035487) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced adult use of a child product (Verbatim: Pediatric dose probably  given to adult) and underdose (Verbatim: Pediatric dose probably  given to adult). The outcome of the adult use of a child product and underdose were unknown.   Additional Information: GSK Receipt Date: 27-MAR-2023 Nurse called to inform that around 2017, a dose of Engerix-B of unknown dosing (pediatric or adult) was administered to an adult patient.  HCP provided the lot number, but it wasn't found in system. However, HCP stated that it was from GlaxoSmithKline and that it was most likely for adult but was not completely sure. The reporter did not consent to follow up. The adult patient received dose of Engerix B, which led to underdose and adult use of child product. This case is linked with US2023046123 and US2023046121, reported by same reporter.; Sender's Comments:  US-GSK-US2023046121:Same reporter US-GSK-US2023046122:Same reporter
red rash (slightly raised small red spots) on arms and shoulders. Mostly on injection arm, less on opposite arm.  No itching, swelling or discomfort. Noticed on day 4 after injection and lasted about 4 days
Patient presents with ? Corona Virus Concern     Tested positive 1/13. Fatigue at home.  "my oxygen was low at home (84%)" Pulse ox 97% in traige on room air     Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 75y.o. male with a past medical history of DVT, CVA, HLD, urinary incontinence from prostate cancer s/p prostatectomy (2008) and non-Hodgkin's lymphoma presenting to the emergency department on 1-19-2022 for chief complaint of shortness of breath and weakness.  Patient states that he recently tested positive for COVID on 13th of  January. He previously had lunch with one of his friends who had a close contact with a covid positive individual. The patient was asymptomatic when he was tested. He has been experiencing symptoms about 2-3 days after testing COVID-positive. He noticed being short of breath and a non productive cough. He denies fever or chills during this time.  Prior to coming to the into the emergency department his pulse ox that he was checking at home had dropped to 84%.  He does note decreased appetite during this time, although he denies nausea or vomiting. He complains of soft stools with 1-2 bowel movements per day. He has received 2 doses of Pfizer vaccine and a booster. His last chemotherapy was in December of last year and he is not currently taking any immunosuppressant medication.    ED COURSE:  BP 85/51, HR 84, RR 20, SPO2 97%, temp 97.8.  CHEM profile remarkable for carbon dioxide 18, albumin 3.3.  CBC remarkable for WBC 2.5, hemoglobin 10.1, hematocrit 31, platelets 133.  Lactate dehydrogenase 442, troponin negative.  CRP 101.7, procalcitonin 0.35.  Ferritin 2505.  Lactic acid 0.5. Placed on 4L NC.    EKG: Pending    Radiology performed: CXR with bibasilar opacities.
Within 10 minutes of receiving the vaccine, my skin broke out in hives, was itchy and hot.  I took over the counter Benadryl about an hour later.  The hives subsided but the itching lasted approximately 24 hours after injection.  I called the clinic and spoke to a nurse who in turn recommended my primary physician contact me.  My primary physician and I spoke by phone the next day.  No office visit was scheduled.
Body ache; Fever of 100 for 12 hours; Chills; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 at 13:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included atorvastatin calcium (LIPITOR) received on unspecified date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 04Mar2021 at 13:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 26Mar2021 at 01:00, the patient experienced fever of 100 (unspecified units) for 12 hours, chills, headache, body ache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken as a result of the reported events. The clinical outcome of the event fever was resolved on 26Mar2021 at 13:00 (for 12 hours) while that of the events chills, headache, body ache and fatigue was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
I broke out with a rash all over my body along with a 101 temperature for the week. The Nurse Practitioner thought that it may have been COVID and it went on for three weeks. I ended up with the symptoms but not the virus so they worked to get me back to normal.
I GET DIZZY WHEN I ROLL OVER IN BED OR  STAND UP. I HAD THE SAME DIZZY SPELLS WITH THE FIRST TWO INJECTIONS OF THE MEDERNA VACCINATION. IT WENT AWAY AFTER A FEW DAYS.
Case reference number 199901649411, is a spontaneous report from 59year of female pt /physician assist. The pt is allergic to oral codeine (GI SX and NSAIDS) She is hypertensive and takes blood pressure medications (NOS).  ON 05/08/98, the pt received her first dose of Havrix for prophylaxis of Hep A. During the summer of 1998, she began to lose her hair. She lost 2/3 of hair volume . A doctor visit was required. She was treated with biotin 300mg/ day and zinc 200 mg / BID. Havrix was discontinued. The most recent information receivid on 07/01/99 reports the condition of the pt is not yet recovered.
I was coughing and sneezing and the next day I was still sneezing. And I went to med express and they told me that I was positive. They told me I was exposed 3 days ago. And I went to church so I told the church and they sent out and email to everyone. I never had a fever, I only had the coughing and I didn?t have the infusion until a week later. And after that I got a little better.
Had strong flu-like event night of 9/14 - 9/15. Recovery (Tired, achy) 9/15.   Woke up with HSV- eye symptoms  in/around right eye 9/16 (Swelling, Irritation, weeping, Redness of sclera, ulcerations near eye and at opening of right nostril)   Went to clinic (noted above), and was prescribed Viroptic (trifluridine) drops.  Will pickup prescription 09/22 . Currently symptoms have lessened slightly (Swelling less pronounced,  irritation lessened slightly).